Earnings History Data for CareDx (CDNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

CareDx

CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
28-02-2024	AH		CDNA	CareDx	447.00	-2.21	-0.24	0.00	CareDx Non-GAAP EPS of -$0.17 beats by $0.10, revenue of $65.6M beats by $1.54M [2/28/2024 4:11 PM]	10.59	0.87 (8.90%)	9.72	0.0 (0.00%)	4.80 - 16.54	3,179,729	700,000	135,905
CareDx Non-GAAP EPS of -$0.17 beats by $0.10, revenue of $65.6M beats by $1.54M [2/28/2024 4:11 PM]
08-11-2023	AH		CDNA	CareDx, Inc.	351.01	-0.43	-0.67	-0.32	CareDx Non-GAAP EPS of -$0.18 beats by $0.22, revenue of $67.2M beats by $14.05M [11/8/2023 4:15 PM]	7.24	0.91 (14.30%)	8.09	1.76 (27.80%)	4.80 - 18.04	2,822,668	1,350,000	107,927
CareDx Non-GAAP EPS of -$0.18 beats by $0.22, revenue of $67.2M beats by $14.05M [11/8/2023 4:15 PM] CareDx stock climbs after Q3 beats, guidance boost [11/9/2023 12:31 PM]
08-08-2023	AH		CDNA	CareDx, Inc.	597.10	-0.46	-0.56	-0.41	CareDx Non-GAAP EPS of -$0.18 beats by $0.13, revenue of $70.3M beats by $8.53M [8/8/2023 4:24 PM]	9.85	-1.19 (-10.78%)	11.40	0.36 (3.26%)	6.22 - 25.84	1,202,129	880,000	1,175
CareDx Non-GAAP EPS of -$0.18 beats by $0.13, revenue of $70.3M beats by $8.53M [8/8/2023 4:24 PM]
10-05-2023	AH	4:00 PM ET (May 10)	CDNA	CareDx, Inc.	440.67	-0.44	-0.31	-0.37	CareDx Non-GAAP EPS of -$0.11 misses by $0.01, revenue of $77.26M misses by $3.44M [5/10/2023 4:15 PM]	8.36	-0.23 (-2.68%)	6.93	-1.66 (-19.32%)	6.22 - 27.35	1,399,784	740,000	50,557
CareDx Non-GAAP EPS of -$0.11 misses by $0.01, revenue of $77.26M misses by $3.44M [5/10/2023 4:15 PM] CareDx down 13% after withdrawing 2023 revenue guidance [5/10/2023 5:13 PM]
27-02-2023	AH	4:00 PM ET (Feb 27)	CDNA	CareDx, Inc.	750.06	-0.34	-0.35	-0.31	CareDx Q4 results beat estimates, co guides FY 2023 revenue below consensus [2/27/2023 4:04 PM]	16.85	2.14 (14.55%)	14.71	0.0 (0.00%)	10.50 - 41.50	1,858,461	810,000	23,728
CareDx Q4 results beat estimates, co guides FY 2023 revenue below consensus [2/27/2023 4:04 PM] CareDx Q4 2022 results, 2023 revenue estimate boosts shares 17% [2/28/2023 2:18 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	CDNA	CareDx, Inc.	1,070	-0.32	-0.41	-0.23	CareDx GAAP EPS of -$0.06 beats by $0.33, revenue of $79.4M misses by $3.22M [11/3/2022 4:10 PM]	15.93	-2.80 (-14.95%)	16.50	-2.23 (-11.91%)	14.93 - 50.19	1,279,228	800,000	16,426
CareDx GAAP EPS of -$0.06 beats by $0.33, revenue of $79.4M misses by $3.22M [11/3/2022 4:10 PM] CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week [Nov-02-22 07:01AM] CareDx (CDNA) Reports Q3 Loss, Lags Revenue Estimates [Nov-03-22 06:15PM] CareDx Reports Third Quarter 2022 Results [Nov-03-22 04:01PM] CareDx To Participate in Upcoming Investor Conferences [Nov-04-22 07:00AM]
04-08-2022	AH	4:00 PM ET (Aug 4)	CDNA	CareDx, Inc.	1,230	-0.41	-0.30	-0.04	CareDx Q2 results miss estimates, co revises FY 2022 revenue guidance [8/4/2022 4:03 PM]	26.38	2.08 (8.56%)	21.00	-3.30 (-13.58%)	19.34 - 84.94	1,305,046	620,000	287
CareDx Q2 results miss estimates, co revises FY 2022 revenue guidance [8/4/2022 4:03 PM] CareDx stock slumps 14% as net loss widens, FY22 outlook slashed [8/4/2022 6:11 PM] CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App [Aug-04-22 07:01AM] CareDx (CDNA) Reports Q2 Loss, Lags Revenue Estimates [Aug-04-22 05:45PM] CareDx Reports Second Quarter 2022 Results [Aug-04-22 04:01PM]
05-05-2022	AH	4:00 PM ET (May 5)	CDNA	CareDx, Inc.	1,730	-0.37	-0.30	-0.01	CareDx Non-GAAP EPS of -$0.13 misses by $0.09, revenue of $79.42M beats by $0.17M [5/5/2022 4:33 PM]	25.85	-5.81 (-18.35%)	31.25	-0.41 (-1.30%)	25.14 - 96.88	1,693,813	760,000	521
CareDx Non-GAAP EPS of -$0.13 misses by $0.09, revenue of $79.42M beats by $0.17M [5/5/2022 4:33 PM] CareDx Validates Clinical Performance of AlloMap Kidney to Comprehensively Assess Transplant Rejection [May-05-22 07:00AM] CareDx Reports First Quarter 2022 Results [May-05-22 04:01PM] CareDx (CDNA) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 05:35PM]
24-02-2022	AH	4:00 PM ET (Feb 24)	CDNA	CareDx, Inc.	1,930	-0.31	-0.19	-0.07	CareDx Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $79.22M beats by $1.12M [2/24/2022 4:24 PM]	38.59	-1.36 (-3.40%)	39.50	-0.45 (-1.13%)	34.09 - 96.88	397,986	540,000	1,011
CareDx Non-GAAP EPS of -$0.03 misses by $0.06, revenue of $79.22M beats by $1.12M [2/24/2022 4:24 PM] CareDx Reports Fourth Quarter and Full Year 2021 Results [Feb-24-22 04:01PM] CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates [Feb-24-22 05:50PM]
28-10-2021	AH	4:00 PM ET (Oct 28)	CDNA	CareDx, Inc.	3,670	-0.23	-0.14	-0.06	CareDx EPS beats by $0.05, beats on revenue [10/28/2021 4:02 PM]	50.92	-19.42 (-27.60%)	60.20	-10.14 (-14.42%)	44.57 - 99.83	5,694,880	410,000	10,099
CareDx EPS beats by $0.05, beats on revenue [10/28/2021 4:02 PM] CareDx drops despite Q3 beat amid concerns over regulatory investigations [10/29/2021 10:05 AM] CareDx Reports Third Quarter 2021 Results; Increases Full Year Revenue Guidance [Oct-28-21 04:01PM] CareDx (CDNA) Q3 Earnings and Revenues Beat Estimates [Oct-28-21 05:15PM] CareDx, Inc (CDNA) Q3 2021 Earnings Call Transcript [Oct-29-21 12:31AM] SHAREHOLDER ALERT: Investigation of CareDx, Inc. Announced by Holzer & Holzer, LLC [Oct-29-21 11:35AM] Why CareDx Stock Is Falling Today Despite a Positive Earnings Call [Oct-29-21 11:53AM] CAREDX INVESTIGATION: Block & Leviton Is Investigating CareDx, Inc. For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm [Oct-29-21 02:47PM] Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of CareDx, Inc. (CDNA) Investigation [Oct-29-21 02:50PM] Why Are CareDx Shares Slumping Despite Q3 Earnings Beat? [Oct-29-21 12:03PM] 44 Stocks Moving In Friday's Mid-Day Session [Oct-29-21 12:07PM] CDNA ALERT - Nationally Ranked Shareholder Rights Firm Labaton Sucharow is Investigating CareDx, Inc. (NASDAQ:CDNA) for Potential Securities Violations [Oct-29-21 03:20PM] INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of CareDx, Inc. (CDNA) on Behalf of Investors [Oct-29-21 07:33PM] CareDx Investor Alert [Oct-29-21 06:24PM] HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages CareDx (CDNA) Investors with Significant Losses to Contact Firms Attorneys Now, Firm Investigating Possible Securities Law Violations [Oct-29-21 05:17PM] CDNA Alert: Berman Tabacco Announces Investigation of CareDx, Inc. in Connection with Government Inquiries [Oct-29-21 04:45PM] Thornton Law Firm Announces Investigation into CareDx [Oct-29-21 04:10PM] Wolf Popper LLP Announces Investigation on Behalf of Purchasers of CareDx, Inc. (CDNA) Common Stock [Oct-29-21 03:49PM]
29-07-2021	AH	4:00 PM ET (Jul 29)	CDNA	CareDx, Inc.	4,450	-0.04	-0.09	-0.15	CareDx EPS beats by $0.05, beats on revenue [7/29/2021 4:14 PM]	84.03	-3.48 (-3.98%)	91.00	3.49 (3.99%)	29.86 - 99.83	450,787	400,000	1,048
CareDx EPS beats by $0.05, beats on revenue [7/29/2021 4:14 PM] CareDx Reports 77% Revenue Growth for Second Quarter of 2021 and Increases Full Year Revenue Guidance [Jul-29-21 04:01PM] CareDx (CDNA) Beats Q2 Earnings and Revenue Estimates [Jul-29-21 06:25PM] CareDx, inc (CDNA) Q2 2021 Earnings Call Transcript [Jul-30-21 09:32AM]
05-05-2021	AH	4:00 PM ET (May 5)	CDNA	CareDx, Inc.	4,110	-0.01	-0.14	-0.14	CareDx EPS beats by $0.13, beats on revenue [5/5/2021 4:24 PM]	72.74	-0.44 (-0.60%)	75.00	1.82 (2.49%)	26.61 - 99.83	764,918	400,000	697
CareDx, Inc. to Host Earnings Call [May-05-21 02:30PM] CareDx Reports First Quarter 2021 Results [May-05-21 04:01PM] CareDx (CDNA) Q1 Earnings and Revenues Surpass Estimates [May-05-21 06:55PM]
24-02-2021	AH	4:05 PM ET (Feb 24)	CDNA	CareDx, Inc.	4,190	-0.07	-0.12	-0.11	CareDx EPS beats by $0.06, beats on revenue [2/24/2021 4:04 PM]	79.56	0.53 (0.67%)	80.00	0.97 (1.23%)	13.04 - 99.83	1,807,737	616,619	537
CareDx EPS beats by $0.06, beats on revenue [2/24/2021 4:04 PM] CareDx Expands into the Pre-Transplant Kidney Space through TX Connect [Feb-25-21 07:00AM]
29-10-2020	AH	4:05 PM ET (Oct 29)	CDNA	CareDx, Inc.	2,490	-0.06	-0.19	-0.04	CareDx EPS beats by $0.16, beats on revenue [10/29/2020 4:16 PM]	48.88	-2.23 (-4.36%)	51.11	0.0 (0.00%)	13.04 - 55.88	857,239	364,776	5,940

04-08-2020	AH	4:05 PM ET (Aug 4)	CDNA	CareDx, Inc.	1,630	-0.15	-0.17	-0.19	CareDx EPS beats by $0.08, beats on revenue [8/4/2020 4:08 PM]	36.71	3.16 (9.42%)	34.40	0.85 (2.53%)	13.04 - 37.54	1,039,047	470,325	15,817